CLINICAL_TRIALS trial_result · 2018-06-06

Clinical Trial Update: Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus [Phase 1, Phase 2]

Updates on a Phase 1/2 trial evaluating autologous stem cell transplantation for Type 1 diabetes mellitus, with the study reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Stem Cells Arabia | Conditions: Diabetes Mellitus Type 1, Autoimmune Diseases | Phase 1, Phase 2 | Status: COMPLETED